What the label lists and what reports show

Balanced salt enriched with bicarbonate and dextrose and glutathione side effects

Balanced salt enriched with bicarbonate and dextrose and glutathione's FDA label lists its adverse reactions in its own words. FAERS holds 367 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is endophthalmitis (126 reports).

No generic listed

Check it at the source: the balanced salt enriched with bicarbonate and dextrose and glutathione FDA label on DailyMed (effective January 25, 2024); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions
Postoperative inflammatory reactions as well as incidents of corneal edema and corneal decompensation have been reported. Their relationship to the use of BSS PLUS solution has not been established.

Source: FDA drug label, Alcon Laboratories, Inc., effective January 25, 2024 (SPL set 9b6d7322-4a90-b31e-9fbb-f1fba1343608), via openFDA; the full label on DailyMed

What do FAERS reports show?

367 reports list balanced salt enriched with bicarbonate and dextrose and glutathione among the medicines taken, each a report of something that happened, not proof the medicine caused it; 1 are coded as a death and 55 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 19 reactions below, 1 is named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

The 25 most reported reactions

Endophthalmitis126
Toxic Anterior Segment Syndrome71
Wrong Technique In Product Usage Process (a use or a product term, not a reaction)70
Corneal Oedema (named in the label)50
Corneal Opacity27
Macular Oedema26
Off Label Use (a use or a product term, not a reaction)21
Product Quality Issue (a use or a product term, not a reaction)20
Eye Inflammation19
Non-Infectious Endophthalmitis19
Product Preparation Error18
Visual Acuity Reduced18
Post Procedural Complication15
Hypopyon14
Anterior Chamber Fibrin12
Fibrin11
Hyperaemia11
Pharmaceutical Product Complaint11
Iritis10
Medication Error (a use or a product term, not a reaction)10
Poor Quality Drug Administered (a use or a product term, not a reaction)10
Postoperative Infection10
Wrong Technique In Drug Usage Process (a use or a product term, not a reaction)10
Intraocular Pressure Increased9
Anterior Chamber Cell8

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Balanced salt enriched with bicarbonate and dextrose and glutathione: the full record: label, generics, price, shortages, recalls
Report a side effect to the FDA: MedWatch
Side effects hub: the most reported medicines and reactions